Background Previous studies have suggested that metformin may be useful for preventing
and treating endometrial cancer (EC), while the results have been inconsistent. This …

Endometrial cancer (EC) is the most common malignancy affecting women in developed
countries. Recently, the EC disease burden has changed; therefore, the Global Burden of …

The “gold standard” treatment for endometrial cancer is completely staged surgery, followed
by radiation or chemotherapy, based on the final pathological surgical stage and …

Purpose The aim of this study was to develop a preoperative risk prediction model for lymph
node metastasis in patients with endometrial cancer and to identify a low-risk group before …

Objectives Although patients with grade I and II endometrioid endometrial adenocarcinoma
(EEA) are considered with good prognosis, among them 15%–25% died in 5 years. It is still …

Immunotherapy has experienced remarkable growth recently. Tertiary lymphoid structures
(TLSs) and B cells may play a key role in the immune response and have a survival benefit …

Background: Endometrial cancer (EC) is a major gynecologic adenocarcinoma that arises
from the endometrium. While the incidence of EC is on the rise worldwide, survivorship and …

Objective: The pretreatment neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-
lymphocyte ratio (PLR) have been reported to be useful as markers for prognostic factors …

Aim Appraisal of cancer trends is essential for future cancer control, but relevant studies in
China are scarce due to a lack of long-term data. With 40-years of cancer registry data, we …

Background/Aim: Inflammation and tumor immunology are important in the prognosis of
various cancers. We herein investigated whether pre-treatment neutrophil to lymphocyte …